| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3976795 | Brachytherapy | 2015 | 4 Pages |
Abstract
The recommended dose was defined as 25Â Gy in five fractions. It will be used in a Phase II study to better evaluate tumor and symptom control in patients with extrahepatic biliary tract cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Gian Carlo Mattiucci, Rosa Autorino, Andrea Tringali, Vincenzo Perri, Mario Balducci, Francesco Deodato, Maria Antonietta Gambacorta, Giovanna Mantini, Luca Tagliaferri, Massimiliano Mutignani, Alessio Giuseppe Morganti,